Theranostic targeting of CUB domain containing protein 1 (CDCP1) in multiple subtypes of bladder cancer.
Shalini ChopraKai TrepkaSasank SakhamuriAlberto Carretero-GonzálezJun ZhuEmily A EgusaJie ZhouKevin K LeungNing ZhaoNima HooshdaranFelix Y FengJames A WellsJonathan ChouKenneth W BaylesPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These data establish that CDCP1 is expressed in BC, including TROP2 and NECTIN4-null disease, and suggest that BC can be treated with CDCP1-targeted radiotherapy.